LipoCure

Company Overview

Snapshot

Founded in November 2005 by Yechezkel Barenholz, LipoCure operates with 1–10 employees. The company has raised $8 million across one funding round from 2 investors. In June 2018, Virpax Pharmaceuticals licensed liposome drug delivery technology from LipoCure.

Business overview

LipoCure is a health tech and life sciences company specializing in the development of therapeutics using proprietary liposome-based nano drugs. Its core technology involves novel drug-loading capabilities and drug-release mechanisms, enabling remote drug loading into nano-liposomes and controlled release at targeted sites. This approach is designed to enhance permeability and retention, improve therapeutic effects, and reduce side effects. LipoCure's technology serves the pharmaceutical industry, with applications in treating conditions such as rheumatoid arthritis, multiple sclerosis, and cancer.

Strategic signal

In June 2018, Virpax Pharmaceuticals licensed LipoCure's liposome drug delivery technology. This agreement signals external validation of LipoCure's proprietary platform and its potential for broader application within the pharmaceutical sector, indicating a strategic move towards commercialization and partnership-driven growth.

Company Intelligence Q&A

What is LipoCure's primary focus?

LipoCure focuses on developing therapeutics using proprietary liposome-based nano drugs with novel drug-loading and drug-release capabilities. This technology aims to improve therapeutic effects and reduce side effects for various medical conditions.

Who founded LipoCure?

LipoCure was founded in November 2005 by Professor Yechezkel Barenholz, who is also the co-developer of Doxil.

What significant licensing agreement did LipoCure secure?

In June 2018, LipoCure licensed its liposome drug delivery technology to Virpax Pharmaceuticals, indicating a strategic partnership for its proprietary platform.

What is the total capital raised by LipoCure?

LipoCure has raised a total of $8 million across one funding round.

Which therapeutic areas does LipoCure's technology address?

LipoCure's technology can be used in conjunction with established drugs for the treatment of rheumatoid arthritis, multiple sclerosis, and cancer.